Unique MyDx consumer generated data points are being used for cannabis- related drug discovery
LEARN MORE
SMART DEVICES
The Cannabis Industry’s first hand-held cannabis tester and analyzer. Equipped to accommodate multiple sensors that test for toxins and impurities in the air you breathe, the foods you eat, and the water you drink.
LEARN MORE
The cannabis industry’s first Smart Vaporizer Pen Integrated with Bluetooth technology that will allow for mobile-app control, dose tracking and restrictions, child safety controls, and usage statistics.
LEARN MORE
MyDx360 is a Software As A Service (SAAS)-based community engagement platform designed to help entrepreneurs develop, launch and track the effects and feedback of formulated products on consumers.
LEARN MORE
MyDx will sell/ license cannabis formulations designed to alleviate various ailments. Chemical formulations will be confirmed by formal clinical trials.
LEARN MORE
Syqe Medical is an Israeli start-up that developed a metered-dose vaporiser of raw plants for medical use.
The platform is further comprised of proprietary raw drug Structural-
Modification methods, uniquely identified
preloaded cartridges
and a linked clinical
database serving
physicians, researchers
and healthcare entities.
MyDx is a science and technology company that developed a dosage-controlled vaporiser that allows consumers to discover what works best for them based on their own physiologies. With a proprietary flow meter, users can determine how many “puffs” it takes to achieve the effect they’re looking for with any lab-tested concentrate.
Linked to the MyDx360 platform, consisting of the MyDx ONE App and cloud database, serving physicians, administrators and the MyDx Community.
| ($mm) | Description | Market Cap | 2016A Sales | Multiple | |
|---|---|---|---|---|---|
 |
GW Pharmaceuticals plc is a biopharmaceutical company focused on developing and commercializing therapeutics from it's cannabinoid product platform in a range of disease areas. | $ | 2,900 $ | 13 | 223.1x |
 |
Aphria Inc., is a Canada-based company, which is engaged in producing and selling medical marijuana through retail sales and whoesale channels. | $ | 1,080 $ | 20 | 54.0x |
 |
Cara Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing chemical entites designed to alleviate pain and pruritus by focusing on kappa opioid receptors. | $ | 430 $ | - | N/A |
 |
AXIM Biotechnologies, Inc. is a biotechnology company engaged in developing the treatment of pain, spasticity, anxiety and other medical disorders with the application of cannabinds-based products. | $ | 424 $ | - | N/A |
 |
Corbus Pharmaceuticals Holdings, Inc. is a clinical-stage pharmaceutical company. The Company is focused on the development and commercialization of therapeutics to treat rare, chronic and serious inflammatory and fibrotic diseases. | $ | 348 $ | 2 | 174.0x |
 |
CanniMed Therapeutics Inc is a Canada-based plant biopharmaceutical company. It is Specicalized in the rpduction of pharmaceutical-grade cannabis. Through it's subsbidiary CanniMed Ltd. the comapany offers medical cannabis oils, dried medical cannabis, vaporizers, vaporizer, vaporizer parts and accessories. | $ | 264 $ | 10 | 26.4x |
 |
Aynerba Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company is engaged in developing and commercializing transdermal synthetic cannabinoid treatments for patients with high unmet needs. | $ | 133 $ | - | N/A |
| Mean Median |
$ $ |
997 424 |
119.4x 119.4x |
||
 |
MyDx is a science and technology company that develops smart devices that allows consumers to discover what works best for them based on their own physiologies. | $ | 7 | - | 8.75x |
Chairman | CEO | Founder
Experienced Executive
Over 15 years of product research, development and commercialization experience
Scientist for Pfizer Pharmaceuticals, specializing in Chemical R&D technologies
Strategic Product & Market Developer for Panasonic, engineering new products with strategic partners in the consumer electronics & healthcare industries
Seasoned asset-backed investor at Yazbeck Investments
M.S. from McGill University
VP Software Engineering
Experienced software manager and engineer who created the MyDx App Responsible for building and managing the foundational software to support sensory testing devices Over 25 years of software development and management experience with his own online companies and with fortune 500 companies
He has been a lead developer and software manager in the U.S. NAVY, SAIC, Jacobs Laboratories,
Boeing and Unidev
VP Operations | Co-Founder
Responsible for optimizing the company's sales systems and affiliate network, as well as better managing customer service processes and procedures Seasoned social media expert on all platforms – integral in establishing MyDx’s social media presence
B.A. Economics from UCSB
Director R&D
Specialty in data analytics, hardware and software systems
Served in the US Marine Corps in their Legal Affairs Department
Has been with MyDx since 2014 supporting product development
Disclaimer: All statements and expressions are the sole opinion of the Company and are subject to change without notice. The Company is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial advisor, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. Information contained herein contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities and Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be "forward looking statements". Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of words such as "expects", "will", "anticipates", "estimates", "believes", or by statements indicating certain actions "may", "could", "should" or "might" occur.
